Literature DB >> 24056274

Cavernous sinus syndrome secondary to intracranial lymphoma in a cat.

Julien Guevar1, Rodrigo Gutierrez-Quintana1, George Peplinski1, Jenny R Helm1, Jacques Penderis2.   

Abstract

Cavernous sinus syndrome is characterised by internal and external ophthalmoplegia and sensory deficits over the head due to combined deficits of the three cranial nerves (CNs) responsible for the eye movements and pupil function (CN III, IV, VI) and at least one branch of the trigeminal nerve (CN V). It has rarely been described in cats and may occur secondarily to inflammatory, infectious or neoplastic lesions within the region of the cavernous sinus on the ventral aspect of the calvarium. This report describes the clinical and magnetic resonance imaging findings in a 14-year-old domestic shorthair cat with neurological deficits compatible with cavernous sinus syndrome caused by presumptive extranodal lymphoma. Treatment with chemotherapy resulted in clinical and imaging remission. Identification of the neurological deficits in cavernous sinus syndrome allows accurate neuroanatomical localisation in order to target diagnostic imaging studies. © ISFM and AAFP 2013.

Entities:  

Mesh:

Year:  2013        PMID: 24056274     DOI: 10.1177/1098612X13505580

Source DB:  PubMed          Journal:  J Feline Med Surg        ISSN: 1098-612X            Impact factor:   2.015


  3 in total

1.  Peripheral cranial neuropathies consistent with cavernous sinus syndrome caused by extracranial nasopharyngeal lymphoma in a cat.

Authors:  Stephanie C Osinchuk; Danielle M Zwueste; Bruce H Grahn
Journal:  Can Vet J       Date:  2019-11       Impact factor: 1.008

2.  Cavernous sinus syndrome in dogs and cats: case series (2002-2015).

Authors:  Aslynn M Jones; Ellison Bentley; Helena Rylander
Journal:  Open Vet J       Date:  2018-05-26

3.  Clinical and magnetic resonance imaging features of lymphoma involving the nervous system in cats.

Authors:  Alexane Durand; Erin Keenihan; Daniela Schweizer; Arianna Maiolini; Julien Guevar; Anna Oevermann; Rodrigo Gutierrez-Quintana
Journal:  J Vet Intern Med       Date:  2022-01-20       Impact factor: 3.333

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.